Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Asset Utilization Ratio (2010 - 2013)

Updated

Kazia Therapeutics' Asset Utilization Ratio was 0.00 in FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Asset Utilization Ratio (2010 - 2013) Analysis & Trends

From FY2009 onward, Kazia Therapeutics has reported Asset Utilization Ratio for 13 fiscal years.

  • The FY2025 figure marks the lowest annual Asset Utilization Ratio since FY2015.
  • Per Business Quant data, Asset Utilization Ratio in earlier fiscal years was 0.11 in FY2024 and 0.37 in FY2021 (+695.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 0.60
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 0.50
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 0.47
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 0.51
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 0.50
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 0.41
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 0.62
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 0.31
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 0.19
Aug 30, 2013 0.20
Dec 31, 2012 0.60
Dec 31, 2011 0.36
Dec 31, 2010 0.33
API Access

Kazia Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KZIA&period=max&api_key=YOUR_API_KEY